Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (FRA:FDY)

Market Cap	747.09M -26.5%
Revenue (ttm)	82.35M -11.7%
Net Income	-19.16M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.2620
Previous Close	0.2620
Day's Range	0.2620 - 0.2620
52-Week Range	0.2340 - 0.3660
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 15, 2026

About FRA:FDY

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd., engages in the research, development, manufacture, and sale of biopharmaceutical products in the People's Republic of China. It offers photodynamic technology drugs, such as aminolevulinic acid hydrochloride and hemoporfin for Injection; doxorubicin liposome under the Libord brand; genetic engineering drugs; and oral solid preparation technology drugs. The company was founded in 1996 and is based in Shanghai, the People's Republic of China.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1996
• Employees: 876
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FDY

Financial Performance

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jul 28, 2026

Data Sources Report a data error